25 Sep 09


Written by Healthblognews.com. No comments

FDA Defers Final Action On Milnacipran New Drug Application

Forest Laboratories, Inc. (NYSE: FRX) and Cypress Bioscience, Inc. (Nasdaq: CYPB) (the “Companies”) announced that the U.S.


Filed under: Fibromyalgia - Trackback Uri



Leave a Comment